An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines

References

• National Institute on Drug Abuse. National overdose deaths: number of deaths from opioid drugs. 2017; Available at: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed October 6, 2017.
   Google Scholar
• Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief. 2009;(22):1–8. PMID:19796521.
   PubMedGoogle Scholar
• Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657–659. doi:10.1001/jama.2013.272. PMID:23423407.
   PubMed Web of Science ®Google Scholar
• Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1–2):8–18. doi:10.1016/j.drugalcdep.2012.07.004. PMID:22857878.
   PubMed Web of Science ®Google Scholar
• Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. Am J Public Health. 2016;106(4):686–688. doi:10.2105/AJPH.2016.303061. PMID:26890165.
   PubMed Web of Science ®Google Scholar
• U.S. Food & Drug Administration (FDA) News Release. FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use. 2016; Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm518697.htm. Accessed October 6, 2017.
   Google Scholar
• US Department of Health and Human Services (HHS), Office of the Surgeon General. Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. Washington, DC: HHS, November 2016
   Google Scholar
• Nielsen S, Lintzeris N, Bruno R, et al. Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med. 2015;16(2):356–366. doi:10.1111/pme.12594. PMID:25279706.
   PubMed Web of Science ®Google Scholar
• Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30(7):557–564. PMID:24281273.
   PubMed Web of Science ®Google Scholar
• Boscarino JA, Hoffman SN, Han JJ. Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates. Subst Abuse Rehabil. 2015;6:83–91. doi:10.2147/SAR.S85667. PMID:26316838.
   PubMed Web of Science ®Google Scholar
• Kan CC, Breteler MH, Zitman FG. High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand. 1997;96(2):85–93. doi:10.1111/j.1600-0447.1997.tb09911.x. PMID:9272191.
   PubMed Web of Science ®Google Scholar
• Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. Bmj. 2015;350:h2698. doi:10.1136/bmj.h2698. PMID:26063215.
   PubMed Web of Science ®Google Scholar
• Zedler B, Xie L, Wang L, et al. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med. 2014;15(11):1911–1929. doi:10.1111/pme.12480. PMID:24931395.
   PubMed Web of Science ®Google Scholar
• Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940–947. doi:10.1001/jama.2012.234. PMID:22396516.
   PubMed Web of Science ®Google Scholar
• Morasco BJ, Duckart JP, Carr TP, Deyo RA, Dobscha SK. Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain. 2010;151(3):625–632. doi:10.1016/j.pain.2010.08.002. PMID:20801580.
   PubMed Web of Science ®Google Scholar
• Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. The Clinical journal of pain. 2013;29(2):102–108. doi:10.1097/AJP.0b013e3182490bdb. PMID:23269280.
   PubMed Web of Science ®Google Scholar
• Department of Veterans Affairs Office of the Inspector General. Report No. 14–00895-163: healthcare Inspection—VA patterns of dispensing take-home opioids and monitoring patients on opioid therapy. 2014; Available at: http://www.va.gov/oig/apps/info/OversightReports.aspx. Accessed October 6, 2017.
   Google Scholar
• Department of Veterans Affairs Under Secretary for Health. Memorandum to network directors: opioid safety initiative requirements. April 2, 2014.
   Google Scholar
• Department of Veterans Affairs Acting Deputy Under Secretary for Health for Operations and Management. Memorandum to VISN directors: opioid safety initiative updates. December 10, 2014; Available at: https://www.va.gov/vhapublications/index.cfm.
   Google Scholar
• Department of Veterans Affairs Under Secretary for Health. Informational letter: implementation of opioid overdose education and naloxone distribution (OEND) to reduce risk of opioid-related death. May 13, 2014.
   Google Scholar
• Department of Veterans Affairs Assistant Deputy Under Secretary for Health for Clinical Operations. Memorandum to network directors: opioid safety initiative progress report. July 2, 2015.
   Google Scholar
• Department of Veterans Affairs Veterans Health Administration Directive 1005. Informed consent for long-term opioid therapy for pain. 2014; Available at: http://www.va.gov/vhapublications/publications.cfm?pub=1. Accessed October 6, 2017.
   Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49. doi:10.15585/mmwr.rr6501e1. PMID:26987082.
   PubMed Web of Science ®Google Scholar
• Perry PJ. Psychotropic Drug Handbook. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
   Google Scholar
• Fuller MA, Sajatovic M. Drug Information Handbook for Psychiatry: Including Psychotropic, Non-Psychotropic, and Herbal Agents. Hudson, Ohio: Lexi-Comp; 2009.
   Google Scholar
• IBM. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp; 2012
   Google Scholar
• Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44(4):1049–1060. doi:10.2307/2531734. PMID:3233245.
   PubMed Web of Science ®Google Scholar
• Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–130. doi:10.2307/2531248. PMID:3719049.
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130. doi:10.1016/j.jpain.2008.10.008. PMID:19187889.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Abdi S, Atluri S, et al. American Society of interventional pain physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance. Pain Physician. 2012;15(3 Suppl):S67–S116. PMID:22786449.
   PubMed Web of Science ®Google Scholar
• The Opioid Therapy for Chronic Pain Work Group. VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain. Version 3.0. Washington, DC: Veterans Health Administration and Department of Defense, 2017
   Google Scholar
• Kim D, Irwin KS, Khoshnood K. Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99(3):402–407. doi:10.2105/AJPH.2008.136937. PMID:19150908.
   PubMed Web of Science ®Google Scholar
• Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health. 2010;87(6):931–941. doi:10.1007/s11524-010-9495-8. PMID:20967505.
   PubMed Web of Science ®Google Scholar
• Alcorn T. America embraces treatment for opioid drug overdose. Lancet. 2014;383(9933):1957–1958. doi:10.1016/S0140-6736(14)60928-4. PMID:24936622.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. CDC Grand Rounds: prescription drug overdoses—a U.S. epidemic. MMWR Morb Mort Wkly Rep. 2012;61:10–13.
   PubMedGoogle Scholar
• Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15(3):184–191. doi:10.1097/00002508-199909000-00005. PMID:10524471.
   PubMed Web of Science ®Google Scholar
• Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097–1102. table of contents. doi:10.1213/01.ANE.0000080159.83342.B5. PMID:14500164.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Pampati V, Damron KS, Beyer CD, Barnhill RC. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician. 2003;6(2):173–178. PMID:16883377.
   PubMedGoogle Scholar
• Schuckman H, Hazelett S, Powell C, Steer S. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache. Subst Use Misuse. 2008;43(5):589–595. doi:10.1081/JA-200030572. PMID:18393078.
   PubMed Web of Science ®Google Scholar
• Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(4 Suppl):S76–82. doi:10.1097/00002508-200207001-00009. PMID:12479257.
   PubMed Web of Science ®Google Scholar
• Michna E, Jamison RN, Pham LD, et al. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain. 2007;23(2):173–179. doi:10.1097/AJP.0b013e31802b4f95. PMID:17237667.
   PubMed Web of Science ®Google Scholar
• Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8(7):573–582. doi:10.1016/j.jpain.2007.02.432. PMID:17499555.
   PubMed Web of Science ®Google Scholar
• Simeone R, Holland L. An Evaluation of Prescription Drug Monitoring. In: Justice UDto, ed. Washington, DC: Office of Justice Programs; 2006
   Google Scholar
• Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR. Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy. Subst Abuse. 2009;3:41–51. PMID:24357929.
   PubMedGoogle Scholar
• Blumenschein K, Fink JL, Freeman PR, Kirsh KL, Steinke DT, Talbert J. Independent evaluation of the impact and effectiveness of the kentucky all schedule prescription electronic reporting program (KASPER). In: Institute of Pharmaceutical Outcomes and Policy DoPPaS, ed. University of Kentucky, Lexington, Kentucky: College of Pharmacy; 2010
   Google Scholar
• Baehren DF, Marco CA, Droz DE, Sinha S, Callan EM, Akpunonu P. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2010;56(1):19–23. e11–13. doi:10.1016/j.annemergmed.2009.12.011. PMID:20045578.
   PubMed Web of Science ®Google Scholar
• Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–584. doi:10.1111/j.1526-4637.2006.00254.x. PMID:17883742.
   PubMed Web of Science ®Google Scholar
• Goldberg KC, Simel DL, Oddone EZ. Effect of an opioid management system on opioid prescribing and unscheduled visits in a large primary care clinic. JCOM. 2005;12(12):621–628.
   Google Scholar
• Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician. 2006;9(1):57–60. PMID:16700282.
   PubMedGoogle Scholar
• Cunningham JL, Evans MM, King SM, Gehin JM, Loukianova LL. Opioid Tapering in Fibromyalgia Patients: experience from an Interdisciplinary Pain Rehabilitation Program. Pain Med. 2016;17(9):1676–1685. doi:10.1093/pm/pnv079. PMID:26755658.
   PubMed Web of Science ®Google Scholar
• Belleville G, Morin CM. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy. Health Psychol. 2008;27(2):239–248. doi:10.1037/0278-6133.27.2.239. PMID:18377143.
   PubMed Web of Science ®Google Scholar
• Morin CM, Belanger L, Bastien C, Vallieres A. Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behav Res Ther. 2005;43(1):1–14. doi:10.1016/j.brat.2003.12.002. PMID:15531349.
   PubMed Web of Science ®Google Scholar
• Paquin AM, Zimmerman K, Rudolph JL. Risk versus risk: a review of benzodiazepine reduction in older adults. Expert Opin Drug Saf. 2014;13(7):919–934. doi:10.1517/14740338.2014.925444. PMID:24905348.
   PubMed Web of Science ®Google Scholar
• Gorgels WJ, Oude Voshaar RC, Mol AJ, et al. Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Fam Pract. 2006;23(1):65–72. doi:10.1093/fampra/cmi065. PMID:16107495.
   PubMed Web of Science ®Google Scholar
• Weimer MB, Hartung DM, Ahmed S, Nicolaidis C. A chronic opioid therapy dose reduction policy in primary care. Subst Abus. 2016;37(1):141–147. doi:10.1080/08897077.2015.1129526. PMID:26685018.
   PubMed Web of Science ®Google Scholar
• Vorma H, Naukkarinen HH, Sarna SJ, Kuoppasalmi KI. Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence. Subst Use Misuse. 2005;40(4):499–510. doi:10.1081/JA-200052433. PMID:15830732.
   PubMed Web of Science ®Google Scholar